Abstract
Objectives
Minimal extrathyroid extension (mETE) was removed from the TNM staging system. This study was designed prospectively to compare the safety and efficacy of microwave ablation (MWA) versus surgery for treating T1N0M0 papillary thyroid carcinomas (PTC) with sonographically detected mETE.
Methods
From December 2019 to April 2021, 198 patients with T1N0M0 mETE-PTCs evaluated by preoperative ultrasound from 10 hospitals were included. Ninety-two patients elected MWA, and 106 patients elected surgery for treatment. MWA was performed using extensive ablation with hydrodissection. Surgery consisted of lobectomy with ipsilateral central lymph node dissection (CLD), lobe and isthmus excision with ipsilateral CLD and total thyroidectomy with ipsilateral CLD. The rates of technical success, cost, oncologic outcomes, complications and quality of life of the two groups were assessed.
Results
The follow-up times for the MWA and surgery groups were 12.7 ± 4.1 and 12.6 ± 5.0 months, respectively. The technical success rate was 100% for both groups. Oncological outcomes of the two groups were similar during the follow-up (all p > 0.05). The MWA group had a shorter operation time, less blood loss and lower costs (all p < 0.001). Three complications (3.3%) were reported in the MWA group and 4 (3.8%) in the surgery group (p = 0.846). The surgery group had higher scores for scar problems and anxiety (p < 0.001 and p = 0.003, respectively).
Conclusions
Microwave ablation was comparable in the short term to surgery in terms of treatment safety and efficacy in selected patients with T1N0M0 mETE-PTC detected by ultrasound.
Key Points
• Microwave ablation is comparable to surgery in the safety and short-term efficacy for PTCs with sonographically detected mETE.
• Thermal ablation is technically feasible for mETE-PTC treatment.
• Patients with mETE-PTC have similar quality of life in the two groups, except for worse scar problems and anxiety in the surgery group.
Similar content being viewed by others
Abbreviations
- CLD :
-
Central lymph node dissection
- gETE :
-
Gross extrathyroid extension
- HADS:
-
Hospital Anxiety and Depression Scale
- LNMs:
-
Lymph node metastasis
- LTP :
-
Local tumour progression
- mETE :
-
Minimal extrathyroid extension
- MWA :
-
Microwave ablation
- PTC :
-
Papillary thyroid carcinoma
- TA :
-
Thermal ablation
- THYCA-QoL:
-
Thyroid Cancer-specific Quality of Life
- US :
-
Ultrasound
References
Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM (2017) Trends in thyroid cancer incidence and mortality in the United States, 1974-2013. JAMA 317(13):1338–1348
Lubitz CC, Sosa JA (2016) The changing landscape of papillary thyroid cancer: epidemiology, management, and the implications for patients. Cancer 122(24):3754–3759
Povoa AA, Teixeira E, Bella-Cueto MR et al (2020) Clinicopathological features as prognostic predictors of poor outcome in papillary thyroid carcinoma. Cancers (Basel) 12(11)
Ito Y, Hirokawa M, Jikuzono T et al (2007) Extranodal tumor extension to adjacent organs predicts a worse cause-specific survival in patients with papillary thyroid carcinoma. World J Surg 31(6):1194–1201
Sia MA, Tsang RW, Panzarella T, Brierley JD (2010) Differentiated thyroid cancer with extrathyroidal extension: prognosis and the role of external beam radiotherapy. J Thyroid Res 2010:183461
Sobin LH, Compton CC (2010) TNM seventh edition: what's new, what's changed: communication from the International Union Against Cancer and the American Joint Committee on Cancer. Cancer 116(22):5336–5339
Tran B, Roshan D, Abraham E et al (2018) An analysis of The American Joint Committee on Cancer 8th Edition T Staging System for Papillary Thyroid Carcinoma. J Clin Endocrinol Metab 103(6):2199–2206
Haugen BR, Alexander EK, Bible KC et al (2016) 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 26(1):1–133
Kim JH, Baek JH, Lim HK et al (2018) 2017 Thyroid Radiofrequency Ablation Guideline: Korean Society of Thyroid Radiology. Korean J Radiol 19(4):632–655
Lang BH-H, Wong CKH (2016) Lobectomy is a more cost-effective option than total thyroidectomy for 1 to 4 cm papillary thyroid carcinoma that do not possess clinically recognizable high-risk features. Ann Surg Oncol 23(11):3641–3652
Kazaure HS, Zambeli-Ljepovic A, Oyekunle T et al (2021) Severe hypocalcemia after thyroidectomy: an analysis of 7366 patients. Ann Surg 274(6):e1014–e1021
Sethukumar P, Ly D, Awad Z, Tolley NS (2018) Scar satisfaction and body image in thyroidectomy patients: prospective study in a tertiary referral centre. J Laryngol Otol 132(1):60–67
Dobrinja C, Pastoricchio M, Troian M et al (2017) Partial thyroidectomy for papillary thyroid microcarcinoma: is completion total thyroidectomy indicated? Int J Surg 41(Suppl 1):S34–S39
Nahm HJ, Choi SJ, Lim YC (2019) Conservative thyroidectomy for papillary thyroid microcarcinoma. Am J Otolaryngol 40(3):427–430
Zhang M, Tufano RP, Russell JO et al (2020) Ultrasound-guided radiofrequency ablation versus surgery for low-risk papillary thyroid microcarcinoma: results of over 5 years’ follow-up. Thyroid 30(3):408–417
Cao XJ, Liu J, Zhu YL et al (2020) Efficacy and safety of thermal ablation for solitary T1bN0M0 papillary thyroid carcinoma: a multicenter study. J Clin Endocrinol Metab 106(2):e573–e581
Cao XJ, Wang SR, Che Y et al (2021) Efficacy and safety of thermal ablation for treatment of solitary T1N0M0 papillary thyroid carcinoma: a multicenter retrospective study. Radiology 300(1):209–216
Zhang M, Luo Y, Zhang Y, Tang J (2016) Efficacy and safety of ultrasound-guided radiofrequency ablation for treating low-risk papillary thyroid microcarcinoma: a prospective study. Thyroid 26(11):1581–1587
Kim JH, Baek JH, Sung JY et al (2017) Radiofrequency ablation of low-risk small papillary thyroidcarcinoma: preliminary results for patients ineligible for surgery. Int J Hyperthermia 33(2):212–219
Association CUD (2019) Expert consensus of thermal ablation treatment for papillary thyroid microcarcinoma. Chin J Med Ultrasound 16(8):571–574
Moon SJ, Kim DW, Kim SJ, Ha TK, Park HK, Jung SJ (2014) Ultrasound assessment of degrees of extrathyroidal extension in papillary thyroid microcarcinoma. Endocr Pract 20(10):1037–1043
Wu J, Zhao ZL, Cao XJ et al (2021) A feasibility study of microwave ablation for papillary thyroid cancer close to the thyroid capsule. Int J Hyperthermia 38(1):1217–1224
Husson O, Haak HR, Mols F et al (2013) Development of a disease-specific health-related quality of life questionnaire (THYCA-QoL) for thyroid cancer survivors. Acta Oncol 52(2):447–454
Annunziata MA, Muzzatti B, Bidoli E et al (2020) Hospital Anxiety and Depression Scale (HADS) accuracy in cancer patients. Support Care Cancer 28(8):3921–3926
Zhu CY, Sha S, Tseng CH et al (2020) Trends in the surgical management of known or suspected differentiated thyroid cancer at a single institution, 2010–2018. Thyroid 30(11):1639–1645
Lim HK, Cho SJ, Baek JH et al (2019) US-guided radiofrequency ablation for low-risk papillary thyroid microcarcinoma: efficacy and safety in a large population. Korean J Radiol 20(12):1653–1661
Teng DK, Li HQ, Sui GQ et al (2019) Preliminary report of microwave ablation for the primary papillary thyroid microcarcinoma: a large-cohort of 185 patients feasibility study. Endocrine 64(1):109–117
Bergenfelz A, Salem AF, Jacobsson H et al (2016) Risk of recurrent laryngeal nerve palsy in patients undergoing thyroidectomy with and without intraoperative nerve monitoring. Br J Surg 103(13):1828–1838
Sippel RS, Robbins SE, Poehls JL et al (2020) A randomized controlled clinical trial: no clear benefit to prophylactic central neck dissection in patients with clinically node negative papillary thyroid cancer. Ann Surg 272(3):496–503
Xiao J, Zhang M, Zhang Y et al (2020) Efficacy and safety of ultrasonography-guided radiofrequency ablation for the treatment of T1bN0M0 papillary thyroid carcinoma: a retrospective study. Int J Hyperthermia 37(1):392–398
Yan L, Lan Y, Xiao J, Lin L, Jiang B, Luo Y (2021) Long-term outcomes of radiofrequency ablation for unifocal low-risk papillary thyroid microcarcinoma: a large cohort study of 414 patients. Eur Radiol 31(2):685–694
Bortz MD, Kuchta K, Winchester DJ, Prinz RA, Moo-Young TA (2020) Extrathyroidal extension predicts negative clinical outcomes in papillary thyroid cancer. Surgery:1–5
Hay ID, Johnson TR, Thompson GB, Sebo TJ, Reinalda MS (2016) Minimal extrathyroid extension in papillary thyroid carcinoma does not result in increased rates of either cause-specific mortality or postoperative tumor recurrence. Surgery 159(1):11–19
Woo CG, Sung CO, Choi YM et al (2015) Clinicopathological significance of minimal extrathyroid extension in solitary papillary thyroid carcinomas. Ann Surg Oncol 22(Suppl 3):S728–S733
Hu S, Zhang H, Sun Z et al (2020) Preoperative assessment of extrathyroidal extension of papillary thyroid carcinomas by ultrasound and magnetic resonance imaging: a comparative study. Radiol Med 125(9):870–876
Chung SR, Baek JH, Choi YJ et al (2020) Sonographic assessment of the extent of extrathyroidal extension in thyroid cancer. Korean J Radiol 21(10):1187–1195
Dobrinja C, Troian M, Cipolat Mis T et al (2017) Rationality in prophylactic central neck dissection in clinically node-negative (cN0) papillary thyroid carcinoma: is there anything more to say? A decade experience in a single-center. Int J Surg 41(Suppl 1):S40–S47
Moreno MA, Edeiken-Monroe BS, Siegel ER, Sherman SI, Clayman GL (2012) In papillary thyroid cancer, preoperative central neck ultrasound detects only macroscopic surgical disease, but negative findings predict excellent long-term regional control and survival. Thyroid 22(4):347–355
Bayona A, Benavent P, Muriel A et al (2021) Outcomes of repeat fine needle aspiration biopsy for AUS/FLUS thyroid nodules. A systematic review and meta-analysis. Eur J Endocrinol 185(4):497–506
Acknowledgements
All authors contributed to the idea, gathered the information, interpreted the data, and wrote and approved the final version of the manuscript.
Funding
The authors state that this work has not received any funding.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Guarantor
The scientific guarantor of this publication is Ping Liang.
Conflict of interest
The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.
Statistics and biometry
No complex statistical methods were necessary for this paper.
Informed consent
Written informed consent was obtained from all subjects (patients) in this study.
Ethics approval
Institutional Review Board approval was obtained.
Methodology
• prospective
• diagnostic or prognostic study
• multicentre study performed at one institution
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
ESM 1
(DOCX 35 kb)
Rights and permissions
About this article
Cite this article
Zheng, L., Dou, Jp., Liu, Fy. et al. Microwave ablation vs. surgery for papillary thyroid carcinoma with minimal sonographic extrathyroid extension: a multicentre prospective study. Eur Radiol 33, 233–243 (2023). https://doi.org/10.1007/s00330-022-08962-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-022-08962-6